Synopsis
In September 2022, Mark Cuban Cost Plus Drugs Company CEO Alex Oshmyansky considered the future of the company. Cost Plus Drugs was a retailer for more than 340 generic oral medications, selling their drugs at significantly lower prices than typical pharmacies. Oshmyansky could focus resources on adding brand-name drugs to its medication portfolio or focus on the company’s ongoing development of a facility to manufacture sterile injectable drugs.
Book Details
ISBN-13 :
Publisher :
Harvard Business Publishing
Date of Addition:
2023-01-19T01:10:40Z
Language :
eng
Categories :
Nonfiction
Usage Restrictions:
Copyright.